Conversion of psychological stress into cellular stress response: Roles of the sigma-1 receptor in the process

Psychiatry and Clinical Neurosciences

Volumn 69, Issue 4, 2015, Pages 179-191

  Hayashi, Teruo ^a  

^a Seiwakai Nishikawa Hospital   (Japan)

Author keywords

Endoplasmic reticulum stress; Oxidative stress; Psychological stress; Sigma 1 receptor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ACTIVATING TRANSCRIPTION FACTOR 6; CALCIUM ION; CHAPERONE; DOPAMINE; FLUVOXAMINE; GLUTAMIC ACID; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; OPIATE AGONIST; OPIATE ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN IRE1; PROTEIN KINASE; PROTEIN KINASE RNA LIKE ENDOPLASMIC RETICULUM KINASE; REACTIVE OXYGEN METABOLITE; SEROTONIN UPTAKE INHIBITOR; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

AUTOOXIDATION; BIPOLAR DEPRESSION; BIPOLAR MANIA; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELL MEMBRANE; CELL NUCLEUS; CELLULAR STRESS RESPONSE; ENDOPLASMIC RETICULUM STRESS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL DISEASE; MENTAL STRESS; MICROGLIA; MORPHOGENESIS; MYELINATION; NERVE CELL LESION; NERVE FIBER GROWTH; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN FOLDING; PROTEIN SYNTHESIS INHIBITION; REVIEW; SCHIZOPHRENIA; SYNAPTOGENESIS; UNFOLDED PROTEIN RESPONSE; ANIMAL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

ANIMALS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, SIGMA; STRESS, PSYCHOLOGICAL;

EID: 84926167081     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12262     Document Type: Review

References (101)

1. Sanchez S, Barnhart S, Stellman S, Cone J, Brackbill R,. 0073 PTSD and cognitive impairment among rescue and recovery workers exposed to the 9/11 World Trade Centre disaster. Occup. Environ. Med. 2014; 71 (Suppl. 1): A68-A69.
2. Nagane A, Baba H, Nakano Y, et al. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: Class-specific influence by tricyclic antidepressants and newer antidepressants. Psychiatry Res. 2014; 218: 101-105.
3. Kultz D,. Evolution of the cellular stress proteome: From monophyletic origin to ubiquitous function. J. Exp. Biol. 2003; 206: 3119-3124.
4. Manie SN, Lebeau J, Chevet E,. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: An update. Am. J. Physiol. Cell Physiol. 2014; 307: C901-C907.
5. Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ,. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol. Aspects Med. 2011; 32: 279-304.
6. Schroder M, Kaufman RJ,. The mammalian unfolded protein response. Annu. Rev. Biochem. 2005; 74: 739-789.
7. Punyiczki M, Fesus L,. Heat shock and apoptosis. The two defense systems of the organism may have overlapping molecular elements. Ann. N. Y. Acad. Sci. 1998; 851: 67-74.
8. Harding HP, Zhang Y, Ron D,. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999; 397: 271-274.
9. Cullinan SB, Diehl JA,. Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell Biol. 2006; 38: 317-332.
10. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K,. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001; 107: 881-891.
11. Smith MH, Ploegh HL, Weissman JS,. Road to ruin: Targeting proteins for degradation in the endoplasmic reticulum. Science 2011; 334: 1086-1090.
12. Bernasconi R, Molinari M,. ERAD and ERAD tuning: Disposal of cargo and of ERAD regulators from the mammalian ER. Curr. Opin. Cell Biol. 2011; 23: 176-183.
13. Chaudhari N, Talwar P, Parimisetty A, Lefebvre d'Hellencourt C, Ravanan P,. A molecular web: Endoplasmic reticulum stress, inflammation, and oxidative stress. Front Cell Neurosci. 2014; 8: 213.
14. Santos CX, Tanaka LY, Wosniak J, Laurindo FR,. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: Roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 2009; 11: 2409-2427.
15. Cadet JL, Brannock C,. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 1998; 32: 117-131.
16. Wang JF, Li Y, Song JN, Pang HG,. Role of hydrogen sulfide in secondary neuronal injury. Neurochem. Int. 2014; 64: 37-47.
17. Gu HF, Tang CK, Yang YZ,. Psychological stress, immune response, and atherosclerosis. Atherosclerosis 2012; 223: 69-77.
18. Katsuura S, Kuwano Y, Yamagishi N, et al. MicroRNAs miR-144/144∗ and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci. Lett. 2012; 516: 79-84.
19. Vassilopoulos D, Mantzoukis D,. Dialogue between the brain and the immune system in inflammatory arthritis. Ann. N. Y. Acad. Sci. 2006; 1088: 132-138.
20. Smith EM, Cadet P, Stefano GB, Opp MR, Hughes TK Jr,. IL-10 as a mediator in the HPA axis and brain. J. Neuroimmunol. 1999; 100: 140-148.
21. Weigelt K, Carvalho LA, Drexhage RC, et al. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behav. Immun. 2011; 25: 1162-1169.
22. Liu Y, McNamara RK,. Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder. J. Psychiatr. Res. 2011; 45: 269-272.
23. Maletic V, Raison C,. Integrated neurobiology of bipolar disorder. Front Psychiatry 2014; 5: 98.
24. Currie S, LeBlanc S, Watters MA, Gilmour KM,. Agonistic encounters and cellular angst: Social interactions induce heat shock proteins in juvenile salmonid fish. Proc. Biol. Sci. 2010; 277: 905-913.
25. Chu TT, Liu Y,. An integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes. J. Hum. Genet. 2010; 55: 285-292.
26. Kowalczyk M, Owczarek A, Suchanek R, et al. Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population. Cell Stress Chaperones 2014; 19: 205-215.
27. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K,. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 2007; 62: 711-721.
28. Epel ES, Lithgow GJ,. Stress biology and aging mechanisms: Toward understanding the deep connection between adaptation to stress and longevity. J. Gerontol. A Biol. Sci. Med. Sci. 2014; 69 (Suppl. 1): S10-S16.
29. Blake MJ, Buckley DJ, Buckley AR,. Dopaminergic regulation of heat shock protein-70 expression in adrenal gland and aorta. Endocrinology 1993; 132: 1063-1070.
30. Gold PW, Licinio J, Pavlatou MG,. Pathological parainflammation and endoplasmic reticulum stress in depression: Potential translational targets through the CNS insulin, klotho and PPAR-gamma systems. Mol. Psychiatry 2013; 18: 154-165.
31. Kawada K, Iekumo T, Saito R, et al. Aberrant neuronal differentiation and inhibition of dendrite outgrowth resulting from endoplasmic reticulum stress. J. Neurosci. Res. 2014; 92: 1122-1133.
32. Nevell L, Zhang K, Aiello AE, et al. Elevated systemic expression of ER stress related genes is associated with stress-related mental disorders in the Detroit Neighborhood Health Study. Psychoneuroendocrinology 2014; 43: 62-70.
33. So J, Warsh JJ, Li PP,. Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biol. Psychiatry 2007; 62: 141-147.
34. Hayashi A, Kasahara T, Kametani M, Toyota T, Yoshikawa T, Kato T,. Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol. 2009; 12: 33-43.
35. Kusumi I, Masui T, Kakiuchi C, et al. Relationship between XBP1 genotype and personality traits assessed by TCI and NEO-FFI. Neurosci. Lett. 2005; 391: 7-10.
36. Kakiuchi C, Ishiwata M, Umekage T, et al. Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin. Neurosci. 2004; 58: 438-440.
37. Cheng D, Zhang K, Zhen G, Xue Z,. The -116C/G polymorphism in XBP1 gene is associated with psychiatric illness in Asian population: A meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2014; 165: 665-672.
38. Bown CD, Wang JF, Chen B, Young LT,. Regulation of ER stress proteins by valproate: Therapeutic implications. Bipolar Disord. 2002; 4: 145-151.
39. Chuang DM,. The antiapoptotic actions of mood stabilizers: Molecular mechanisms and therapeutic potentials. Ann. N. Y. Acad. Sci. 2005; 1053: 195-204.
40. Kim B, Kim CY, Lee MJ, Joo YH,. Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders. Psychiatry Res. 2009; 168: 209-212.
41. Lester HA, Miwa JM, Srinivasan R,. Psychiatric drugs bind to classical targets within early exocytotic pathways: Therapeutic effects. Biol. Psychiatry 2012; 72: 907-915.
42. Su TP, Hayashi T,. Understanding the molecular mechanism of sigma-1 receptors: Towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr. Med. Chem. 2003; 10: 2073-2080.
43. Hayashi T, Su TP,. Sigma-1 receptor ligands: Potential in the treatment of neuropsychiatric disorders. CNS Drugs 2004; 18: 269-284.
44. Hanner M, Moebius FF, Flandorfer A, et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl Acad. Sci. U.S.A. 1996; 93: 8072-8077.
45. Xu J, Zeng C, Chu W, et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nat. Commun. 2011; 2: 380.
46. Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE,. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol. Sci. 2010; 31: 557-566.
47. Hashimoto K,. Sigma-1 receptors and selective serotonin reuptake inhibitors: Clinical implications of their relationship. Cent. Nerv. Syst. Agents Med. Chem. 2009; 9: 197-204.
48. Hayashi T, Tsai SY, Mori T, Fujimoto M, Su TP,. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert. Opin. Ther. Targets 2011; 15: 557-577.
49. Omi T, Tanimukai H, Kanayama D, et al. Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor. Cell Death Dis. 2014; 5: e1332.
50. Tsai SY, Hayashi T, Harvey BK, et al. Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway. Proc. Natl Acad. Sci. U.S.A. 2009; 106: 22468-22473.
51. Hayashi T, Su TP,. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc. Natl Acad. Sci. U.S.A. 2004; 101: 14949-14954.
52. Maurice T, Lockhart BP,. Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands. Prog. Neuropsychopharmacol. Biol. Psychiatry 1997; 21: 69-102.
53. Mitsuda T, Omi T, Tanimukai H, et al. Sigma-1Rs are upregulated via PERK/eIF2alpha/ATF4 pathway and execute protective function in ER stress. Biochem. Biophys. Res. Commun. 2011; 415: 519-525.
54. Tuerxun T, Numakawa T, Adachi N, et al. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression. Neurosci. Lett. 2010; 469: 303-308.
55. Noda Y, Kamei H, Kamei Y, Nagai T, Nishida M, Nabeshima T,. Neurosteroids ameliorate conditioned fear stress: An association with sigma receptors. Neuropsychopharmacology 2000; 23: 276-284.
56. Villard V, Meunier J, Chevallier N, Maurice T,. Pharmacological interaction with the sigma1 (sigma1)-receptor in the acute behavioral effects of antidepressants. J. Pharmacol. Sci. 2011; 115: 279-292.
57. Ritsner MS, Bawakny H, Kreinin A,. Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: An 8-week, double-blind, randomized add-on two-center trial. Psychiatry Clin. Neurosci. 2014; 68: 432-440.
58. Hayashi T, Su TP,. Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. J. Pharmacol. Exp. Ther. 2003; 306: 726-733.
59. Hayashi T, Su TP,. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: Roles in endoplasmic reticulum lipid compartmentalization and export. J. Pharmacol. Exp. Ther. 2003; 306: 718-725.
60. Hayashi T, Su TP,. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007; 131: 596-610.
61. Hayashi T, Rizzuto R, Hajnoczky G, Su TP,. MAM: More than just a housekeeper. Trends Cell Biol. 2009; 19: 81-88.
62. Fujimoto M, Hayashi T,. New insights into the role of mitochondria-associated endoplasmic reticulum membrane. Int. Rev. Cell Mol. Biol. 2011; 292: 73-117.
63. Hajnoczky G, Davies E, Madesh M,. Calcium signaling and apoptosis. Biochem. Biophys. Res. Commun. 2003; 304: 445-454.
64. Rizzuto R, Brini M, Murgia M, Pozzan T,. Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 1993; 262: 744-747.
65. Vance JE, Vance DE,. Phospholipid biosynthesis in mammalian cells. Biochem. Cell Biol. 2004; 82: 113-128.
66. Voelker DR,. Bridging gaps in phospholipid transport. Trends Biochem. Sci. 2005; 30: 396-404.
67. Mavlyutov TA, Epstein ML, Andersen KA, Ziskind-Conhaim L, Ruoho AE,. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 2010; 167: 247-255.
68. Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, Bonci A,. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 2013; 152: 236-247.
69. Ortega-Roldan JL, Ossa F, Schnell JR,. Characterization of the human sigma-1 receptor chaperone domain structure and binding immunoglobulin protein (BiP) interactions. J. Biol. Chem. 2013; 288: 21448-21457.
70. Hedskog L, Pinho CM, Filadi R, et al. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl Acad. Sci. U.S.A. 2013; 110: 7916-7921.
71. Mori T, Hayashi T, Hayashi E, Su TP,. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS ONE 2013; 8: e76941.
72. Hayashi T, Hayashi E, Fujimoto M, Sprong H, Su TP,. The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones. J. Biol. Chem. 2012; 287: 43156-43169.
73. Yang T, Espenshade PJ, Wright ME, et al. Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002; 110: 489-500.
74. Meunier J, Hayashi T,. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB. J. Pharmacol. Exp. Ther. 2010; 332: 388-397.
75. Mori T, Hayashi T, Su TP,. Compromising sigma-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-kappaB/Bcl-2-dependent mechanism: Potential relevance to Parkinson's disease. J. Pharmacol. Exp. Ther. 2012; 341: 663-671.
76. Tsai SY, Rothman RK, Su TP,. Insights into the Sigma-1 receptor chaperone's cellular functions: A microarray report. Synapse 2012; 66: 42-51.
77. Zhao J, Ha Y, Liou GI, Gonsalvez GB, Smith SB, Bollinger KE,. Sigma receptor ligand, (+)-pentazocine, suppresses inflammatory responses of retinal microglia. Invest. Ophthalmol. Vis. Sci. 2014; 55: 3375-3384.
78. Ruscher K, Inacio AR, Valind K, Rowshan Ravan A, Kuric E, Wieloch T,. Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke. PLoS ONE 2012; 7: e45118.
79. Allahtavakoli M, Jarrott B,. Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats. Brain Res. Bull. 2011; 85: 219-224.
80. Takebayashi M, Hayashi T, Su TP,. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: Implications for antidepressants. J. Pharmacol. Exp. Ther. 2002; 303: 1227-1237.
81. Takebayashi M, Hayashi T, Su TP,. A perspective on the new mechanism of antidepressants: Neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 2004; 37 (Suppl. 3): S208-S213.
82. Nishimura T, Ishima T, Iyo M, Hashimoto K,. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: Role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS ONE 2008; 3: e2558.
83. Hayashi A, Kasahara T, Iwamoto K, et al. The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J. Biol. Chem. 2007; 282: 34525-34534.
84. Hayashi A, Kasahara T, Kametani M, Kato T,. Attenuated BDNF-induced upregulation of GABAergic markers in neurons lacking Xbp1. Biochem. Biophys. Res. Commun. 2008; 376: 758-763.
85. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, Glimcher LH,. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 2003; 4: 321-329.
86. Ghafourifar P, Mousavizadeh K, Parihar MS, Nazarewicz RR, Parihar A, Zenebe WJ,. Mitochondria in multiple sclerosis. Front. Biosci. 2008; 13: 3116-3126.
87. D'Ambrosi N, Rossi S, Gerbino V, Cozzolino M,. Rac1 at the crossroad of actin dynamics and neuroinflammation in amyotrophic lateral sclerosis. Front Cell Neurosci 2014; 8: 279.
88. Li L, Xu B, Zhu Y, Chen L, Sokabe M, Chen L,. DHEA prevents Aβ25-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology 2010; 59: 323-333.
89. Duman RS, Li N, Liu RJ, Duric V, Aghajanian G,. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012; 62: 35-41.
90. Matsuno K, Kobayashi T, Tanaka MK, Mita S,. Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur. J. Pharmacol. 1996; 312: 267-271.
91. Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP,. Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav. Brain Res. 2009; 198: 472-476.
92. Kishi T, Yoshimura R, Okochi T, et al. Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology 2010; 58: 1168-1173.
93. Miyatake R, Furukawa A, Matsushita S, Higuchi S, Suwaki H,. Functional polymorphisms in the sigma1 receptor gene associated with alcoholism. Biol. Psychiatry 2004; 55: 85-90.
94. Maurice T, Casalino M, Lacroix M, Romieu P,. Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice. Pharmacol. Biochem. Behav. 2003; 74: 869-876.
95. Luty AA, Kwok JB, Dobson-Stone C, et al. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann. Neurol. 2010; 68: 639-649.
96. Al-Saif A, Al-Mohanna F, Bohlega S,. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2011; 70: 913-919.
97. Tagashira H, Shinoda Y, Shioda N, Fukunaga K,. Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2014; 1840: 3320-3334.
98. Mavlyutov TA, Epstein ML, Verbny YI, et al. Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience 2013; 240: 129-134.
99. Peviani M, Salvaneschi E, Bontempi L, et al. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol. Dis. 2014; 62: 218-232.
100. Ono Y, Tanaka H, Takata M, et al. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci. Lett. 2014; 559: 174-178.
101. Mancuso R, Olivan S, Rando A, Casas C, Osta R, Navarro X,. Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurother 2012; 9: 814-826.